Keywords: watson, seeking, market, generic, enablex, usa, novartis

Watson seeking to market generic Enablex in USA; Novartis files patent infringement suit

Article | 30 April 2009

Print This

USA-based Watson has asked the Food and Drug Administration to approve a generic version of Swiss drug major Novartis' Enablex ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in